CClinicalTrials.gg
CompletedNCT02761135Updated May 22, 2018

Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?

An observational study in Prostate Cancer, sponsored by Kronoberg County Council. Completed at 1 site in Sweden. Open to male participants. Per ClinicalTrials.gov, last updated 2018-05-22.

Sponsored by Kronoberg County Council · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
364
Sex
Male
01

Study summary

Prostate cancer is the most common cancer among men in Sweden. During investigation of suspected cancer transrectal ultrasound with needle biopsies from prostate leeds to diagnosis.

The most common technique today is side-fire where the needle enter the prostate in angle from the probe. In end-fire technique the needle enters the prostate at tip of probe without angle. The difference in techniques side-fire vs. end-fire affects the possibility to reach the ventral and apical aspects of prostate.

Today´s standard is at least five cores from each side of the prostate at first biopsy. If first sample is negative there will usually be another urological exam and a first re-biopsy.

The study aim to compare these two methods in cancer detection. The investigators' hypothesis is that when using end-fire technique at first re-biopsy, investigators find more cancers compared to side-fire.

Patients are prospectively randomized into two groups, both assessing 12 core biopsies according to study protocol.

Primary endpoint is cancer detection. Data will be collected about patient age, PSA-level, prostate size, digital rectal exam, hypoechogenic zones and length of cancers.

02

Conditions studied

  • Prostate Cancer

Browse trials for

Keywords

  • Biopsy technique
  • Transrectal ultrasonography probe
  • Side-fire
  • Prostate cancer
  • End-fire
03

In context

Prostatic Neoplasms

6,370 studies on the registry are indexed under Prostatic Neoplasms; 1,400 are open to participants now.

This study's enrollment of 364 is above the median of 200 across 1,181 observational studies indexed under Prostatic Neoplasms.

Browse Prostatic Neoplasms studies →

Lead sponsor

Kronoberg County Council is the lead sponsor of 13 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Men admitted to Urological reception in Vaxjo and Ljungby for a first-time re-biopsy for investigating prostate cancer.

Inclusion criteria

  • first re-biopsy
  • PSA over 3ng/ml
  • T1c to T2a palpatory finding

Exclusion criteria

Exclusion Criteria:

  • prostate cancer
  • T2b or more advanced cancer
  • more than one previous biopsy done
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
364 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Side-fire

    Using side-fire technique during transrectal ultrasound.

  • End-fire

    Using end-fire technique during transrectal ultrasound.

06

What researchers measure

Primary outcomes

  1. Cancer detection

    After finished study inclusion, data will be analyzed and presented within 12-18 months.

    Time frame: Study inclusion continues until 400 patients is included. Estimated time frame from study start 5 years.

07

Study locations

1 site
  • Section of Urology, Department of surgery, Regional Hospital Växjö
    Växjö, Kronoberg, Sweden
08

References and documents

Publications

  • Ortegren J, Holmberg JT, Lekas E, Mana S, Martensson S, Richthoff J, Sundqvist P, Kjolhede H, Bratt O, Liedberg F. A randomised trial comparing two protocols for transrectal prostate repeat biopsy: six lateral posterior plus six anterior cores versus a standard posterior 12-core biopsy. Scand J Urol. 2019 Aug;53(4):217-221. doi: 10.1080/21681805.2019.1628102. Epub 2019 Jun 17. PubMed 31204873 ↗

Individual participant data

Plan to share: Yes

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02761135
Lead sponsor
Kronoberg County Council
Responsible party
Sponsor
First posted
May 4, 2016
Start date
Jan 2011
Primary completion
Mar 2018
Completion
Mar 2018
Last update
May 22, 2018

Study contacts

Joakim Ortegren
principal investigator · Section of Urology, Department of Surgery, Växjö County Hospital, Växjö, Sweden

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion